When it comes to staying trim, timing may be everything.

That's according to new research that found adults who routinely engaged in moderate-to-vigorous exercise early in the morning were less likely to be overweight or obese than those who worked out later in the day.

“For individuals who exercise regularly, their body mass index [BMI] is 2 units lower and waist circumference is...

Low-carb diets may be all the rage, but they're not for kids with diabetes, according to the American Academy of Pediatrics (AAP).

In a new report, the AAP says that low-carbohydrate diets cannot be recommended for children or teenagers with either type 1 or type 2 diabetes. That's because there's little evidence they're helpful, but there are concerns about restricting kids' diets to tha...

The blockbuster drug Ozempic has become a household name for its ability to spur weight loss. Now an early study hints at an intriguing possibility: The drug might allow people newly diagnosed with type 1 diabetes to drop their daily insulin shots.

Experts emphasized that the findings

Weight-loss drugs like Ozempic and Wegovy are surging in popularity, but that doesn’t mean they’re good for everyone.

Glucagon-like peptide-1 receptor agonists (GLP-1RA) may be dangerous for children, warned researchers at University of California, Irvine.

Treating childhood obesity and type 2 diabetes with these injected medications may have unintended and adverse consequences ...

For women, keeping a stable weight after the age of 60 may boost their odds of reaching the advanced ages of 90, 95 or even 100.

Older women with a more stable weight were 1.2 to 2 times more likely to live that long than those who lost 5% or more of their weight, the study showed.

Women who unintentionally lost weight were 51% less likely to survive to the age of 90. Gaining ...

Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.

Now, injected Wegovy could prove a boon for many patients battling heart failure, a new study suggests. The trial results were presented Friday in Amsterdam at the annual meeting of the European Society of C...

As demand for the wildly popular weight-loss drug Wegovy continues to climb, drug maker Novo Nordisk said Thursday that it will continue restrictions on starter doses of the medication into 2024.

The new plan extends by months existing restrictions and means patients who are not already taking the medication will have to wait to start.

“We are going to continue to supply the marke...

A large clinical trial weighing the medical merits of the obesity drug Wegovy has unearthed a significant positive side effect.

Taking the medication cut the risk of serious heart problems by 20%, drug maker Novo Nordisk announced Tuesday.

“People living with obesity have an increased risk of cardiovascular disease but, to date, there are no approved weight-management medications ...

A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach problems.

The lawsuit seeks “very significa...

Water fasting has become one of the trendiest new weight-loss sensations, touted by former athletes and wellness gurus.

But whatever weight is lost during a water fast can come back quickly, while other health benefits fade fast, according to a